The Webinar from yesterday. Some key points:
1. Funding with 4.77 million in cash plus R&D being announced next week
2. Phase 2 funding coming from the Department of Defence in America. They have non dilutive funding to not cause dilution
3. AGN works differently to NYR but the mechanism of reducing secondary brain injury is the same
4. Safety data continuing to come through
https://youtu.be/ijO5rj8hkeo?si=MtcKJVJa6Qmysgk0
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.82M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 35.0¢ | 31.0¢ | $188.4K | 569.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7500 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 30034 | 2 |
View Market Depth
| Last trade - 15.33pm 22/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |